TG Therapeutics TGTX Inventory write-downs
Inventory write-downs at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InventoryWriteDown.
The official record: TG Therapeutics’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's inventory write-downs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's inventory write-downs?
- TG Therapeutics (TGTX) reported inventory write-downs of $1.54M in Q4 2025.
- What does inventory write-downs mean?
- A non-cash expense recorded when inventory loses value or becomes unsellable.
- How do you interpret inventory write-downs?
- Higher write-downs suggest potential overstocking, product obsolescence, or declining market demand for inventory.
- How does inventory write-downs compare across companies?
- Standard across manufacturing and pharmaceutical sectors to reflect inventory health.